1. Home
  2. ARAI vs ICCC Comparison

ARAI vs ICCC Comparison

Compare ARAI & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ARAI

Arrive AI Inc.

N/A

Current Price

$1.03

Market Cap

63.6M

Sector

Finance

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$6.54

Market Cap

55.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARAI
ICCC
Founded
2020
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.6M
55.5M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
ARAI
ICCC
Price
$1.03
$6.54
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
289.2K
12.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.33
EPS
N/A
0.20
Revenue
N/A
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
$900.00
N/A
P/E Ratio
N/A
$32.15
Revenue Growth
N/A
51.64
52 Week Low
$0.96
$4.32
52 Week High
$15.50
$7.60

Technical Indicators

Market Signals
Indicator
ARAI
ICCC
Relative Strength Index (RSI) 29.09 53.29
Support Level N/A $6.13
Resistance Level $3.37 $6.87
Average True Range (ATR) 0.08 0.24
MACD 0.05 -0.01
Stochastic Oscillator 33.33 68.57

Price Performance

Historical Comparison
ARAI
ICCC

About ARAI Arrive AI Inc.

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advanced chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: